Home/Pipeline/Z-Scanner

Z-Scanner

Breast Cancer Risk Assessment & Early Detection

DevelopmentActive

Key Facts

Indication
Breast Cancer Risk Assessment & Early Detection
Phase
Development
Status
Active
Company

About Zedsen

Zedsen is developing a novel breast cancer screening device, the Z-Scanner, based on Electrical Capacitance Tomography (ECT) and advanced AI/ML algorithms. The technology is designed to be non-invasive, radiation-free, portable, and affordable, targeting improved detection in dense breast tissue and enabling use in primary care clinics. The company is pre-revenue and in the development stage, with a team focused on engineering and data science, aiming to decentralize and democratize early breast cancer detection.

View full company profile

Therapeutic Areas